Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,995,000 | 3,460,000 | 4,947,000 | 975,000 | 4,507,000 |
| Depreciation Amortization | 10,380,000 | 1,746,000 | 637,000 | 789,000 | 382,000 |
| Income taxes - deferred | 983,000 | -924,000 | 45,000 | 453,000 | -204,000 |
| Accounts receivable | -646,000 | 752,000 | -429,000 | -431,000 | -803,000 |
| Other Working Capital | 987,000 | 3,170,000 | 217,000 | 2,145,000 | -1,152,000 |
| Other Operating Activity | 11,343,000 | 6,000 | 1,649,000 | 1,344,000 | 328,000 |
| Operating Cash Flow | $14,052,000 | $8,210,000 | $7,066,000 | $5,275,000 | $3,058,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,108,000 | -152,000 | 74,000 | 979,000 | 1,720,000 |
| PPE Investments | -753,000 | -836,000 | -951,000 | -1,055,000 | -1,215,000 |
| Net Acquisitions | -12,343,000 | -9,092,000 | -1,123,000 | 10,000 | 975,000 |
| Sale Of Investment | 129,000 | 167,000 | N/A | N/A | N/A |
| Investing Cash Flow | $-10,859,000 | $-9,913,000 | $-2,000,000 | $-66,000 | $1,480,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -267,000 | 131,000 | -543,000 | 727,000 | 125,000 |
| Debt Issued | 6,945,000 | 26,778,000 | 0 | 1,488,000 | 0 |
| Debt Repayment | -2,750,000 | -9,256,000 | -5,000 | -1,224,000 | -15,000 |
| Common Stock Repurchased | -1,546,000 | -7,300,000 | -320,000 | -2,469,000 | -231,000 |
| Dividend Paid | -4,075,000 | -2,679,000 | -2,613,000 | -2,577,000 | -2,547,000 |
| Other Financing Activity | 542,000 | -53,000 | -54,000 | -22,000 | 15,000 |
| Financing Cash Flow | $-1,151,000 | $7,621,000 | $-3,535,000 | $-4,077,000 | $-2,653,000 |
| Exchange Rate Effect | 111,000 | -9,000 | -41,000 | 52,000 | -33,000 |
| Beginning Cash Position | 12,820,000 | 6,911,000 | 5,421,000 | 4,237,000 | 2,385,000 |
| End Cash Position | 14,973,000 | 12,820,000 | 6,911,000 | 5,421,000 | 4,237,000 |
| Net Cash Flow | $2,153,000 | $5,909,000 | $1,490,000 | $1,184,000 | $1,852,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 14,052,000 | 8,210,000 | 7,066,000 | 5,275,000 | 3,058,000 |
| Capital Expenditure | -753,000 | -836,000 | -951,000 | -1,055,000 | -1,215,000 |
| Free Cash Flow | 13,299,000 | 7,374,000 | 6,115,000 | 4,220,000 | 1,843,000 |